The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer.
Constantinos ZamboglouChristina Marie KleinBenedikt ThomannThomas Franz FassbenderHans C RischkeSimon KirsteKarl HenneNatalja Volegova-NeherMichael BockMathias LangerPhilipp T MeyerDimos BaltasAnca L GrosuPublished in: Radiation oncology (London, England) (2018)